GW Vaccine Research Unit — Washington D.C., District of Columbia

GW Vaccine Research Unit is a clinical research site located in Washington D.C., District of Columbia, United States 20037.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

GW Vaccine Research Unit has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: RESPIRATORY SYNCYTIAL VIRUS (RSV), Influenza, Human, SARS-CoV-2 Infection.

Sponsors: Pfizer, BioNTech SE.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GW Vaccine Research Unit?

GW Vaccine Research Unit has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GW Vaccine Research Unit conducted?

GW Vaccine Research Unit has 5 clinical trials on record, with 2 currently active. Their work covers RESPIRATORY SYNCYTIAL VIRUS (RSV), Influenza, Human, SARS-CoV-2 Infection.

Is GW Vaccine Research Unit accredited by Crixeo Health?

GW Vaccine Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GW Vaccine Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.